SAN FRANCISCO, March 7, 2017– Opus Biotech Communications, a life sciences public and investor relations consultancy based in Seattle and Atlanta, today announced the opening of a San Francisco office through an affiliation with PJ Johnston Communications, a long established San Francisco based public relations firm.
Opus was founded by Dan Eramian, former first Vice President of Communications for the Biotechnology Industry Organization (BIO), and Charles Craig, a writer and editor for leading biotech publications and mainstream media organizations, and former President of Georgia Bio.
“Having a presence in San Francisco allows us to better serve clients especially our target audience, emerging biotech companies, which need to raise their profile and tell their story to investors but may have limited resources,” said Eramian.
“Opus is pleased to be associated with PJ Johnston Communications,” Craig said. “Mr. Johnston has been a major figure in the San Francisco public relations community and is well known by the media, health care organizations and local government. He has also been a media consultant for the Biotechnology Industry Organization.”
“I am excited to be affiliated with Opus Biotech Communications in its effort to assist emerging companies in the San Francisco Bay area, the home of the most innovative biotech companies in the world,” added Johnston.
The Opus office will be located at 2962 Fillmore Street, San Francisco, CA 94123
San Francisco office (415)-923-8944; Seattle office (425)-306-8716; Atlanta office (404)-245-0591
About PJ Johnston
P.J. Johnston is a media relations consultant, crisis communications specialist and political strategist. With more than 20 years of front-line media experience, Johnston provides expert services to a variety of individuals, businesses and nonprofit organizations, small and large governments, law firms, sports teams, health care organizations, political campaigns and elected officials. For more information please visit our website: http://www.pjcommunications.com/
About Opus Biotech Communications Services
Opus Biotech Communications works with emerging life sciences companies to tell their stories of innovation, perseverance and value at affordable rates. We create strategies for connecting with industry news media, investors, business partners, opinion leaders, and patient groups. Our expertise is in the ability to develop clear, concise and compelling messages informed by extensive experience providing strategic planning in public and investor relations. Opus also offers CEO and company reputation guidance and bioethics consultation on organizational, research, marketing and clinical care issues. To learn more about Opus please visit our website: http://opusbiotech.com/.
.
